

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
The US supreme court has stayed the first scheduled execution of a Texas death-row inmate using pentobarbital.
Cleve Foster was to have been executed on Tuesday evening for the 2002 murder of a Sudanese woman in Fort Worth - the first Texas execution since the state switched to pentobarbital in its lethal three-drug mixture.
On Tuesday morning, the court agreed to reconsider its earlier order denying Foster's appeal that had raised claims of innocence and poor legal help during his trial and the early stages of his appeals.
Foster's lawyers have argued that Texas prison officials violated administrative procedures last month when they announced the switch to pentobarbital from sodium thiopental, which is in short supply nationwide. They contend that the rule change required more time for public comment and review.
Lower courts have rejected their appeals and they had planned to take their case to the Texas supreme court. At the same time, they sought a rehearing before the US supreme court over its rejection of an appeal in January. The court had stopped Foster's then-scheduled execution, but its rejection of his claims a week later cleared the way for Tarrant county authorities to schedule the execution for Tuesday.
In its brief ruling, the court gave prosecutors 30 days to respond to the defence petition, after which the supreme court will decide if the appeal has merit.
The issue over the execution drug was not before the court and the order on Tuesday did not mention it.
The drug swap is the most significant change in the execution procedure in Texas since the state switched from the electric chair to lethal injection when it reinstated capital punishment in 1982. Pentobarbital is a sedative used in surgery and to euthanise animals, and has already been used for executions in Oklahoma and Ohio.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
The US supreme court has stayed the first scheduled execution of a Texas death-row inmate using pentobarbital.
Cleve Foster was to have been executed on Tuesday evening for the 2002 murder of a Sudanese woman in Fort Worth - the first Texas execution since the state switched to pentobarbital in its lethal three-drug mixture.
On Tuesday morning, the court agreed to reconsider its earlier order denying Foster's appeal that had raised claims of innocence and poor legal help during his trial and the early stages of his appeals.
Foster's lawyers have argued that Texas prison officials violated administrative procedures last month when they announced the switch to pentobarbital from sodium thiopental, which is in short supply nationwide. They contend that the rule change required more time for public comment and review.
Lower courts have rejected their appeals and they had planned to take their case to the Texas supreme court. At the same time, they sought a rehearing before the US supreme court over its rejection of an appeal in January. The court had stopped Foster's then-scheduled execution, but its rejection of his claims a week later cleared the way for Tarrant county authorities to schedule the execution for Tuesday.
In its brief ruling, the court gave prosecutors 30 days to respond to the defence petition, after which the supreme court will decide if the appeal has merit.
The issue over the execution drug was not before the court and the order on Tuesday did not mention it.
The drug swap is the most significant change in the execution procedure in Texas since the state switched from the electric chair to lethal injection when it reinstated capital punishment in 1982. Pentobarbital is a sedative used in surgery and to euthanise animals, and has already been used for executions in Oklahoma and Ohio.
The US supreme court has stayed the first scheduled execution of a Texas death-row inmate using pentobarbital.
Cleve Foster was to have been executed on Tuesday evening for the 2002 murder of a Sudanese woman in Fort Worth - the first Texas execution since the state switched to pentobarbital in its lethal three-drug mixture.
On Tuesday morning, the court agreed to reconsider its earlier order denying Foster's appeal that had raised claims of innocence and poor legal help during his trial and the early stages of his appeals.
Foster's lawyers have argued that Texas prison officials violated administrative procedures last month when they announced the switch to pentobarbital from sodium thiopental, which is in short supply nationwide. They contend that the rule change required more time for public comment and review.
Lower courts have rejected their appeals and they had planned to take their case to the Texas supreme court. At the same time, they sought a rehearing before the US supreme court over its rejection of an appeal in January. The court had stopped Foster's then-scheduled execution, but its rejection of his claims a week later cleared the way for Tarrant county authorities to schedule the execution for Tuesday.
In its brief ruling, the court gave prosecutors 30 days to respond to the defence petition, after which the supreme court will decide if the appeal has merit.
The issue over the execution drug was not before the court and the order on Tuesday did not mention it.
The drug swap is the most significant change in the execution procedure in Texas since the state switched from the electric chair to lethal injection when it reinstated capital punishment in 1982. Pentobarbital is a sedative used in surgery and to euthanise animals, and has already been used for executions in Oklahoma and Ohio.